We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$186B
AUM Growth
+$16.6B
Cap. Flow
+$3.17B
Cap. Flow %
1.7%
Top 10 Hldgs %
15.55%
Holding
3,227
New
50
Increased
2,329
Reduced
489
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 18.04%
2 Financials 14.33%
3 Healthcare 12.99%
4 Industrials 10.19%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVFM
3051
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$182K ﹤0.01%
1,962
LEE icon
3052
Lee Enterprises
LEE
$181M
$180K ﹤0.01%
12,666
ADMS
3053
DELISTED
Adamas Pharmaceuticals
ADMS
$178K ﹤0.01%
46,928
KDNY
3054
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$177K ﹤0.01%
29,934
+3,854
+15% +$20.9K
SIEB icon
3055
Siebert Financial
SIEB
$68.4M
$176K ﹤0.01%
20,332
NGNE icon
3056
Neurogene
NGNE
$729M
$174K ﹤0.01%
+703
New +$70K
INSE icon
3057
Inspired Entertainment
INSE
$161M
$169K ﹤0.01%
24,992
METC icon
3058
Ramaco Resources Class A
METC
$645M
$166K ﹤0.01%
47,769
+682
+1% +$2.28K
STIM icon
3059
Neuronetics
STIM
$151M
$166K ﹤0.01%
36,954
RPAY icon
3060
Repay Holdings
RPAY
$317M
$163K ﹤0.01%
11,120
ACRS icon
3061
Aclaris Therapeutics
ACRS
$867M
$161K ﹤0.01%
84,702
TESS
3062
DELISTED
Tessco Technologies Inc
TESS
$161K ﹤0.01%
14,305
-1,995
-12% -$25.3K
RMNI icon
3063
Rimini Street
RMNI
$458M
$160K ﹤0.01%
40,989
SBOW
3064
DELISTED
SilverBow Resources, Inc.
SBOW
$158K ﹤0.01%
15,939
SBBP
3065
DELISTED
Strongbridge Biopharma plc.
SBBP
$158K ﹤0.01%
75,231
CELC icon
3066
Celcuity
CELC
$4.43B
$157K ﹤0.01%
14,709
TUSK icon
3067
Mammoth Energy Services
TUSK
$162M
$156K ﹤0.01%
70,528
+935
+1% +$1.68K
TZOO icon
3068
Travelzoo
TZOO
$73.9M
$156K ﹤0.01%
14,548
CBUS icon
3069
Cibus
CBUS
$146M
$154K ﹤0.01%
437
HNRG icon
3070
Hallador Energy
HNRG
$748M
$151K ﹤0.01%
50,786
YARW
3071
Yarrow Bioscience, Inc. Common Stock
YARW
$112M
$150K ﹤0.01%
9
ASXC
3072
DELISTED
Asensus Surgical, Inc.
ASXC
$150K ﹤0.01%
101,628
+15,697
+18% +$54.5K
AXAS
3073
DELISTED
Abraxas Petroleum Corp
AXAS
$146K ﹤0.01%
20,723
TEUM
3074
DELISTED
Pareteum Corporation
TEUM
$145K ﹤0.01%
330,148
+50,061
+18% +$28.9K
PRPL icon
3075
Purple Innovation
PRPL
$39.6M
$144K ﹤0.01%
+660
New +$127K

Similar funds

Charles Schwab's Q4 2019 Portfolio in Review

As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
  • Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
  • Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
  • Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
  • Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
  • Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.

Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.